BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16289107)

  • 21. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
    Chirkov YY; De Sciscio M; Sverdlov AL; Leslie S; Sage PR; Horowitz JD
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):131-7. PubMed ID: 20490904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
    Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
    Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance.
    Daiber A; Oelze M; Sulyok S; Coldewey M; Schulz E; Treiber N; Hink U; Mülsch A; Scharffetter-Kochanek K; Münzel T
    Mol Pharmacol; 2005 Sep; 68(3):579-88. PubMed ID: 15933216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
    Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
    Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers.
    Singh IN; Sullivan PG; Hall ED
    J Neurosci Res; 2007 Aug; 85(10):2216-23. PubMed ID: 17510982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.
    Daiber A; Münzel T
    Antioxid Redox Signal; 2015 Oct; 23(11):899-942. PubMed ID: 26261901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2.
    Beretta M; Wölkart G; Schernthaner M; Griesberger M; Neubauer R; Schmidt K; Sacherer M; Heinzel FR; Kohlwein SD; Mayer B
    Circ Res; 2012 Feb; 110(3):385-93. PubMed ID: 22207712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALDH-2 deficiency increases cardiovascular oxidative stress--evidence for indirect antioxidative properties.
    Wenzel P; Müller J; Zurmeyer S; Schuhmacher S; Schulz E; Oelze M; Pautz A; Kawamoto T; Wojnowski L; Kleinert H; Münzel T; Daiber A
    Biochem Biophys Res Commun; 2008 Feb; 367(1):137-43. PubMed ID: 18157936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages.
    Leiro JM; Alvarez E; Arranz JA; Cano E; Orallo F
    Int Immunopharmacol; 2004 Feb; 4(2):163-77. PubMed ID: 14996408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans.
    Wenzel P; Schulz E; Gori T; Ostad MA; Mäthner F; Schildknecht S; Göbel S; Oelze M; Stalleicken D; Warnholtz A; Münzel T; Daiber A
    J Pharmacol Exp Ther; 2009 Jul; 330(1):63-71. PubMed ID: 19346443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress.
    Daiber A; Oelze M; Wenzel P; Wickramanayake JM; Schuhmacher S; Jansen T; Lackner KJ; Torzewski M; Münzel T
    Pharmacol Rep; 2009; 61(1):33-48. PubMed ID: 19307691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates.
    Wenzel P; Oelze M; Coldewey M; Hortmann M; Seeling A; Hink U; Mollnau H; Stalleicken D; Weiner H; Lehmann J; Li H; Förstermann U; Münzel T; Daiber A
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1729-35. PubMed ID: 17541025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs modulating the biological effects of peroxynitrite and related nitrogen species.
    Olmos A; Giner RM; Máñez S
    Med Res Rev; 2007 Jan; 27(1):1-64. PubMed ID: 16752428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
    Klemenska E; Beresewicz A
    Cardiol J; 2009; 16(1):11-9. PubMed ID: 19130411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation.
    Szöcs K; Lassègue B; Wenzel P; Wendt M; Daiber A; Oelze M; Meinertz T; Münzel T; Baldus S
    J Mol Cell Cardiol; 2007 Jun; 42(6):1111-8. PubMed ID: 17493633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between hydralazine and nitrovasodilators in vascular smooth muscle.
    Unger P; Berkenboom G; Fontaine J
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):478-83. PubMed ID: 7681511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.